Uncategorised - European Medical Journal

Infographic: ESMO Recommendations for Diagnosis and Staging of Metastatic Non-Small-Cell Lung Cancer

ESMO Recommendations for Diagnosis and Staging of Metastatic Non-Small-Cell Lung Cancer. Bronchoscopy: for central lesions; can be paired with bronchial washing, brushing, and bronchial and transbronchial biopsy

Venous Thromboembolism Risk: The Role of Obesity and Combined Oral Contraceptive Pills

Use of a combined oral contraceptive pill could increase the risk of venous thromboembolism (VTE) for females who are obese by 24-fold…

Gene Variants Linked to Hodgkin Lymphoma

Genome sequencing from 234 members of 36 families has revealed 44 genetic variants associated with increased risk…

Top tips for digital innovation and the future of patient centricity

Helena is joined by well-known pharma conference speaker Konrad Dobschuetz to discuss his top tips for digital innovation in the pharma industry.

Moderna joins BIA as 500th member

Moderna has joined the UK’s BioIndustry Association (BIA), taking the trade association’s membership to over 500 companies.

Interview: Naveed Sattar

EMJ spoke with Naveed Sattar, Professor of Metabolic Medicine, University of Glasgow, about developments in diabetes and awareness of metabolic disease…

Roundtable: a discussion on the pandemic and gender parity

Hear from two industry thought leaders to find out how the pharmaceutical industry is harnessing the COVID-19 to advance rather than derail their mission to improve female representation.

A roundtable on clinical trial transformation

Clinical trials of the past struggled with patient enrolment and cost efficiency. What can the pharmaceutical industry learn to improve them?

Interview: David Leslie

David Leslie Professor of Diabetes and Autoimmunity, Queen Mary University of London, UK joins EMJ to discuss his career and study in diabetes…

Roundtable: the evolving landscape of patient advocacy

In this roundtable, hear from two industry thought leaders who share their ideas on how to build synergy between pharma and patients.